Monday, 18 Jan 2021


8 Medications and Supplements To Leave Behind in 2018

Medications 1) Levofloxacin (Levaquin) Levofloxacin (Levaquin) is an antibiotic often prescribed for routine infections like bacterial sinusitis, urinary tract infections, and pneumonia, but recent warnings from the FDA should diminish levofloxacin’s popularity in 2019. Severe—and potentially permanent—side effects of levofloxacin include tendon rupture, nerve damage, dangerously low blood sugar, and mental health issues. The FDA […]

BioCryst Initiates Phase 1 Clinical Trial of Galidesivir

RESEARCH TRIANGLE PARK, N.C., Jan. 02, 2019 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced the dosing of the first subject in a randomized, placebo-controlled phase 1 clinical trial to evaluate intravenous (IV) galidesivir in healthy volunteers. The main goals of this trial are to evaluate the safety, tolerability and pharmacokinetics of escalating doses […]

Postpartum opioid Rx may lead to persistent use: study

(HealthDay)—New mothers who take opioid painkillers after either vaginal birth or cesarean section may be at increased risk of becoming persistent users, a new study finds. Researchers from Vanderbilt University in Nashville examined data from more than 102,000 new mothers in Tennessee. None had used opioids in the 180 days before delivery. After delivery, 89 […]

FDA Approves Inbrija

ARDSLEY, N.Y.–(BUSINESS WIRE) December 21, 2018 –Acorda Therapeutics, Inc. today announced that the U.S. Food and Drug Administration approved Inbrija™ for intermittent treatment of OFF episodes in people with Parkinson’s disease treated with carbidopa/levodopa. OFF episodes, also known as OFF periods, are defined as the return of Parkinson’s symptoms that result from low levels of […]

Recent Posts